By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Azenta, Inc.

Azenta, Inc. (AZTA)

NASDAQ Currency in USD
$474.00
+$3.92
+0.83%
Last Update: 18 Jul 2026, 12:54
$21.68bn
Market Cap
-119.70
P/E Ratio (TTM)
Forward Dividend Yield
$324.36-$649.95
52 Week Range

AZTA Stock Price Chart

Explore Azenta, Inc. interactive price chart. Choose custom timeframes to analyze AZTA price movements and trends.

AZTA Company Profile

Discover essential business fundamentals and corporate details for Azenta, Inc. (AZTA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

2 Feb 1995

Employees

3.00k

CEO

John Marotta

Description

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

AZTA Financial Timeline

Browse a chronological timeline of Azenta, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 4 Aug 2026

EPS estimate is $0.11, while revenue estimate is $149.24m.

Earnings released on 6 May 2026

EPS came in at -$0.04 falling short of the estimated $0.10 by -140.00%, while revenue for the quarter reached $144.80m , missing expectations by -2.37%.

Earnings released on 4 Feb 2026

EPS came in at $0.09 falling short of the estimated $0.11 by -18.18%, while revenue for the quarter reached $148.64m , beating expectations by +1.06%.

Earnings released on 21 Nov 2025

EPS came in at $0.21 surpassing the estimated $0.19 by +10.82%, while revenue for the quarter reached $159.19m , beating expectations by +1.91%.

Earnings released on 5 Aug 2025

EPS came in at $0.19 surpassing the estimated $0.13 by +46.15%, while revenue for the quarter reached $143.94m , missing expectations by -3.64%.

Earnings released on 7 May 2025

EPS came in at $0.05 falling short of the estimated $0.09 by -44.44%, while revenue for the quarter reached $143.42m , beating expectations by +1.80%.

Earnings released on 5 Feb 2025

EPS came in at $0.08 surpassing the estimated $0.05 by +60.00%, while revenue for the quarter reached $147.51m , beating expectations by +4.39%.

Earnings released on 12 Nov 2024

EPS came in at $0.18 surpassing the estimated $0.11 by +63.64%, while revenue for the quarter reached $656.32m , beating expectations by +286.98%.

Earnings released on 6 Aug 2024

EPS came in at $0.16 surpassing the estimated $0.07 by +128.57%, while revenue for the quarter reached $172.81m , beating expectations by +1.03%.

Earnings released on 8 May 2024

EPS came in at $0.05 surpassing the estimated $0.02 by +167.81%, while revenue for the quarter reached $159.13m , missing expectations by -0.47%.

Earnings released on 7 Feb 2024

EPS came in at $0.02 surpassing the estimated $0.01 by +159.74%, while revenue for the quarter reached $154.32m , beating expectations by +2.20%.

Earnings released on 13 Nov 2023

EPS came in at $0.13 surpassing the estimated $0.02 by +629.11%, while revenue for the quarter reached $172.36m , beating expectations by +5.26%.

Earnings released on 8 Aug 2023

EPS came in at $0.13 surpassing the estimated $0.02 by +714.03%, while revenue for the quarter reached $165.95m , beating expectations by +0.47%.

Earnings released on 9 May 2023

EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%, while revenue for the quarter reached $148.40m , missing expectations by -8.34%.

Earnings released on 8 Feb 2023

EPS came in at $0.12 surpassing the estimated $0.06 by +100.00%, while revenue for the quarter reached $178.37m , missing expectations by -1.66%.

Earnings released on 14 Nov 2022

EPS came in at $0.16 surpassing the estimated $0.06 by +166.67%, while revenue for the quarter reached $137.57m , beating expectations by +2.88%.

Earnings released on 9 Aug 2022

EPS came in at $0.12 surpassing the estimated $0.08 by +50.00%, while revenue for the quarter reached $132.74m , beating expectations by +0.03%.

Earnings released on 9 May 2022

EPS came in at $0.12 surpassing the estimated $0.11 by +9.09%, while revenue for the quarter reached $145.54m , beating expectations by +2.20%.

Earnings released on 8 Feb 2022

EPS came in at $0.12 surpassing the estimated $0.08 by +50.00%, while revenue for the quarter reached $139.65m , beating expectations by +3.06%.

Dividend declared on 2 Dec 2021

A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 23 Dec 2021.

Earnings released on 10 Nov 2021

EPS came in at $0.78 surpassing the estimated $0.77 by +1.30%, while revenue for the quarter reached $136.94m .

Dividend declared on 2 Sept 2021

A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 24 Sept 2021.

Earnings released on 5 Aug 2021

EPS came in at $0.72 surpassing the estimated $0.68 by +5.88%, while revenue for the quarter reached $315.35m .

AZTA Stock Performance

Access detailed AZTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run